Skip to main content

A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.

Sorber L, Zwaenepoel K, Deschoolmeester V, Roeyen G, Lardon F, Rolfo C, Pauwels P

Publication: J Mol Diagn (2017) • Vol 19 • Page 162-168PMID: 27865784View on PubMed

Purpose

This paper investigated the effects of cell-free DNA (cfDNA) isolation kit choice on total and KRAS- mutated cfDNA yield and cfDNA integrity.

Conclusion

The highest total and KRAS cfDNA yields were obtained when cfDNA was isolated with the QIAamp circulating nucleic acid or Maxwell RSC ccfDNA Plasma Kit. Further, the QIAamp circulating nucleic acid or Maxwell RSC ccfDNA Plasma Kit were better able to extract the 105 bp fragment of GAPDH than the other kits resulting in a larger difference in yield of the 105 and 236 bp fragments. Interestingly, extraction with the first version of the NEXTprep-Mag cfDNA Isolation Kit resulted in inhibition of digital droplet PCR, but not real-time PCR.

Studies (1)

Purpose

This study investigated the effects of cfDNA isolation kit choice on total and KRAS-mutated cfDNA yield and cfDNA integrity. Plasma was obtained from two patients with benign pancreatic cysts and seven patients with pancreatic ductal adenocarcinoma (PDAC)(3 who underwent surgery and 4 with metastasized disease). A second specimen was obtained from one of the patients with PDAC with metastasis. No details of blood processing were provided. cfDNA was extracted from plasma using the EpiQuick Circulating Cell-Free DNA Isolation Kit, the first and second versions of the NEXTprep-Mag ccfDNA Isolation Kit, the PME free-circulating DNA Extraction Kit, the QIAamp circulating nucleic acid kit, and the Maxwell RSC cfDNA Plasma Kit.  DNA was quantified using digital droplet PCR and the KRAS Screening Multiplex Kit. DNA integrity was confirmed by real-time PCR of 105 and 236 bp fragments of GAPDH. The KRAS mutational status had been determined previously using DNA extracted from blood (all 10 specimens) using QIAamp circulating nucleic acid kit and from FFPE tissue using Cobas DNA Sample Preparation Kit (5 specimens with KRAS wildtype determined using blood).

Summary of Findings

Compared to the QIAamp circulating nucleic acid, a comparable amount of total cfDNA was isolated using the Maxwell RSC cfDNA Plasma Kit (62.57 copies/µL versus 56.49 copies/µL with QIAamp) and significantly less cfDNA was isolated using the PME free-circulating DNA Extraction Kit (4.06 copies/µL, P<0.0005) or the second version of the NEXTprep-Mag ccfDNA Isolation Kit (6.08 copies/µL, P=0.001). Further, the yield was below the limit of detection for digital droplet PCR for three of 10 specimens isolated using the PME free-circulating DNA Extraction Kit and all 10 specimens isolated using the first version of the NEXTprep-Mag ccfDNA Isolation Kit or the EpiQuick Circulating Cell-Free DNA Isolation Kit. The authors attribute lack of digital droplet PCR products using the first version of the NEXTprep-Mag ccfDNA Isolation Kit to ddPCR inhibiting agents as real-time PCR cycle threshold values were comparable between versions of the NEXTprep-Mag ccfDNA Isolation Kit. While KRAS-mutated DNA was detected in all five KRAS positive specimens when cfDNA was extracted with the QIAamp circulating nucleic acid or Maxwell RSC ccfDNA Plasma Kit, it was detected in only the two specimens with the highest mutational load when cfDNA was extracted with the second version of the NEXTprep-Mag ccfDNA Isolation Kit and was not detected in any specimens extracted with the PME free-circulating DNA Extraction Kit, the first version of the NEXTprep-Mag ccfDNA Isolation Kit, or the EpiQuick Circulating Cell-Free DNA Isolation Kit. 

Although both GAPDH fragments were amplified in all specimens when DNA was extracted with 5 of the 6 kits, when DNA was extracted using the EpiQuick Circulating Cell-Free DNA Isolation Kit only two specimens allowed for amplification and only one fragment was amplified in each.  The difference in amplification between the 105 bp and 236 bp fragment was similar for DNA isolated with the QIAamp circulating nucleic acid or Maxwell RSC ccfDNA Plasma Kit (-9.898 and -8.427, respectively). Compared to the QIAamp circulating nucleic acid, the differences between the 105 and 236 bp fragments were smaller when isolated with the EpiQuick Circulating Cell-Free DNA Isolation Kit (-4.894, P=0.001), the first and second versions of the NEXTprep-Mag ccfDNA Isolation Kit (-4.261, P<0.001 and -4.177, P<0.001, respectively), and the PME free-circulating DNA Extraction Kit (-4.491, P<0.001). 

  • Biospecimens

    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticBenign
  • Platforms

    DNADigital PCR
    DNAReal-time qPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Analyte Extraction and PurificationAnalyte isolation method
    EpiQuick Circulating Cell-Free DNA Isolation Kit
    First version of the NEXTprep-Mag ccfDNA Isolation Kit
    Maxwell RSC cfDNA Plasma Kit
    PME free-circulating DNA Extraction Kit
    QIAamp circulating nucleic acid kit
    Second version of the NEXTprep-Mag ccfDNA Isolation Kit
    Real-time qPCR SpecificLength of gene fragment
    105 bp
    236 bp
    Real-time qPCR SpecificTargeted nucleic acid
    GAPDH
    Real-time qPCR SpecificTechnology platform
    Digital droplet PCR
    Digital PCR SpecificTargeted nucleic acid
    KRAS mutated cfDNA
    Total cfDNA